Rhinocerebral zygomycosis with pansinusitis in a 14-year-old girl with type 1 diabetes: a case report and review of the literature by Annalisa di Coste et al.
Rhinocerebral zygomycosis with pansinusitis
in a 14-year-old girl with type 1 diabetes:
a case report and review of the literature
di Coste et al.
ITALIAN JOURNAL 
OF PEDIATRICS




di Coste et al. Italian Journal of Pediatrics 2013, 39:77
http://www.ijponline.net/content/39/1/77CASE REPORT Open AccessRhinocerebral zygomycosis with pansinusitis
in a 14-year-old girl with type 1 diabetes:
a case report and review of the literature
Annalisa di Coste1*, Francesco Costantino1, Luigi Tarani1, Vincenzo Savastano1, Claudio Di Biasi2, Laura Schiavi1,
Ilaria Ernesti1, Taulant Melengu1 and Marzia Duse1Abstract
Background: Zygomycosis is a rare life-threatening fungal infection affecting mostly patients with predisposing
conditions such as diabetes mellitus, immunodeficiency, haemochromatosis or major trauma.
Methods: We describe a case of rhinocerebral zygomycosis in a girl with type 1 diabetes and review previous
published cases and treatment options.
Results: A 14-year-old girl with type 1 diabetes mellitus occurred with dental pain, facial swelling, ecchymosis and
left eye decreased visual acuity, unresponsive to antibiotic therapy. The coltures of the sinusal mucosa were positive
for fungal species belonging to the Zygomycetes. She performed antifungal therapy with posaconazole (POS) with
a very slow improvement and a poor glycemic control, leading to blindness of the left eye.
Conclusion: Our report adds further awareness on rhinocerebral zygomycosis and emphasizes on urgent diagnosis
and timely management of this potentially fatal fungal infection through an adequate treatment.
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Zygomycosis is a rare life-threatening opportunistic fun-
gal infection in humans, that often complicates diabetes
mellitus and primary and acquired immunodeficiencies
characterised by defects of the cell-mediated immunity.
Other predisposing factors include steroid therapy,
organ transplantation and cytotoxic chemotherapy [1].
The causative organism is an aerobic saprophytic fungus
belonging to the order of Mucorales of the class Zygomy-
cetes. It is ubiquitous insoil, grows rapidly and constantly
discharges spores into the environment [2]. Infection is
usually caused by inhalation of sporangiospores or via
direct contamination of skin wounds, especially burns.
The lungs, nasal cavity and paranasal sinuses, gut and
cutaneous tissues are therefore the most common sites
for primary infection. At onset, Rhinocerebral Zygomy-
cosis presents with different clinical features such as* Correspondence: dicoste.annalisa@gmail.com
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stated.blindness, cranial nerve palsies, eye proptosis and pain.
Fungal hyphae preferentially invade the walls of blood
vessels producing thrombi and infarction. The resulting
progressive tissue ischaemia and necrosis of deep tissues
may include muscle and fat, ultimately leading to multi-
organ failure and sepsis. The central nervous system can
be invaded by Zygomycetes either contiguously from ad-
jacent paranasal sinuses (rhinocerebral zygomycosis), or
haematogenously from a remote site of infection [3]. We
report a case of necrotizing invasive rhinocerebral zygo-
mycosis in a 14-year-old girl with type 1 diabetes and re-
view previous reported cases from 1980 to 2012.Materials and methods
Case presentation
A 14-year-old caucasian girl is followed at our Department
of Pediatrics for type 1 diabetes mellitus since the age
of three years with poor glycemic control despite regu-
lar insulin therapy. She occurred with a 7-day history of
dental pain, facial swelling (extending superiorly from
the supraorbital margin and inferiorly to the angle ofl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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region with decreased visual acuity and colour vision,
unresponsive to antibiotic therapy with amoxicillin.
Physical examination showed left-sided facial numbness,
lagophthalmos with inability to complete closure of the
left eyelid and tongue deviation to the left. Intraorally
there were carious lesions and low sensitivity of the
upper teeth. Biochemical investigations revealed neu-
trophilia and increasing of inflammatory markers. The
electromyography showed a severe VII nerve damage.
Radiographic examination showed haziness of left maxil-
lary sinus with erosion of lateral sinus wall. Magnetic
resonance imaging of her head revealed a marked muco-
sal thickening of the left maxillary sinus extended to the
sphenoid, ethmoid and frontal sinus with moderate in-
flammatory effusion (Figure 1). For three times inflam-
matory tissue was excised from the sinuses through an
Endoscopic Sinus Surgery for microbial eradication and
histopathologic examination. The tissue biopsy showed
fragments of mucosa lined by respiratory epithelium
with chronic aspecific inflammatory infiltrate and gro-
wed fungal species belonging to the Zygomycetes. After
a 20-day treatment with imipenem, teicoplanin, metro-
nidazole and aciclovir, she was given intravenous
amphotericin B to which posaconazole (POS) was imme-
diately replaced, due to the onset of side effects such as
hyperglycemia, marked hypothermia and profuse sweat-
ing. The follow-up magnetic resonance images showed
progression of the disease with significant intracranial
extension. The magnetic resonance angiography showed
the involvement of the neurovascular retromandibular
axis and left cavernous sinus with occlusion of ipsilateral
cavernous carotid and increased signal of the walls ofFigure 1 Magnetic resonance imaging of head. A. Postgadolinium T1-w
(arrow) in the left nasal cavity and periorbital site compatible with necrotic m
internal carotid artery (arrow) and thrombosis of the right cavernous sinus, altthe left middle cerebral artery caused by arteritis. She
continued antifungal drug therapy and clinic follow-up
showing a very slow improvement, a poor glycemic con-
trol and many recurrences, leading to blindness of the
left eye.
Results
Zygomycosis is rare in pediatric patients, and there are
few reports in the literature. We performed a MEDLINE
search for articles published in the English-language litera-
ture, ages: 0–18 years, from January 1980 to September
2013. The search terms used were: rhinocerebral zygomy-
cosis or mucormycosis and case report.
Our search yielded a total of 25 articles including 28
case reports (Table 1). Cases included were those with
acute zygomycosis infection in the rhinocerebral region
diagnosed by histology with or without a positive cul-
ture, with hematologic malignancies or type 1 diabetes
as predisposing factors. Fifteen out of 28 cases (53.6%)
of rhinocerebral zygomycosis from these case series were
found in patients with type 1 diabetes, twelve (42.8%) in
patients with hematologic malignancies and one (3.6%)
in a patient with autoimmune hepatitis.
In described pediatric cases rhinocerebral zygomycosis
presents with a characteristic onset: cranial nerve palsies
(66.7% of cases), facial/eye swelling or blindness (40%),
eye proptosis (33.3%), periorbital cellulitis or pain (20%),
epistaxis, headaches, nasal discharge, decreasing con-
sciousness, dysarthria and otalgia (6.7%).
All cases have the involvement of at least one eye. All
patients underwent surgery and/or therapy with ampho-
tericin B and other antifungal agents. The 25% of pa-
tients with type 1 diabetes has passed the infectioneighted axial magnetic resonance image showing nonenhancing tissue
ucosa. B. Similar technique showing note semiocclusion of the left
hough there was no radiographic evidence of cerebral infarction.
Table 1 Pediatric rhinocerebral zygomycosis: review of the literature from 1980 to 2013
Author Cases (Number) Sex Ages (years) Underlying condition Treatment Outcome
Kilpatrick et al. [4]. 1984 1 F 18 DM 1 Surgery, antifungal therapy Survived with left orbital exenteration
and ethmoidectomy.
Kemper et al. [5]. 1993 1 F 18 DM 1 Surgery, L-AmB, HOT Survived with right eye exenteration
Garces et al. [6]. 1994 1 M 6 Hematologic malignancy Surgery Deceased
Moll et al. [7]. 1994 1 Unknown 12 DM 1 Surgery, antifungal therapy Survived with minimal left cranial nerve palsies
Shah et al. [8]. 1997 1 M 15 DM 1 L-AmB and HOT Survived with a ventriculoperitoneal
shunt, right nonreactive pupil, minimal
residual physical disability
Kameh et al. [9] 1997 1 M 13 months DM 1 Surgery, L-AmB Deceased
Adler et al. [10]. 1998 1 M 16 DM 1 Surgery, L-AmB Survived
Lee et al. [11] 1998 1 M 10 DM 1 Surgery, L-AmB Survived with open craniotomy for
abscess resection
Khanna et al. [12]. 1998 1 F 11 DM 1 Surgery, L-AmB Deceased
Parkin et al. [13]. 2000 2 M; M 13; 3 Hematologic malignancy G-CSF, L-AmB Deceased for other cause; survived after
bone marrow transplant
Ryan et al. [14]. 2001 2 F; M 9;3 Hematologic malignancy Surgery, L-AmB Deceased
Gessesse et al. [15]. 2001 1 M 11 DM 1 Unknown Deceased
Wehl et al. [16]. 2002 1 M 9 months Hematologic malignancy L-AmB Deceased
Hamilton et al. [17]. 2003 1 M 14 DM 1 Surgery, antibiotics, HOT Survived with enucleation of right eye
Simmons et al. [18]. 2005 1 F 8 DM 1 Surgery, L-AmB, HOT, Interferon-G, POS, GM-CSF Survived
Sorensen et al. [19]. 2006 1 F 10 Hematologic malignancy L-AmB, POS, Caspofungin, surgery Deceased for other cause
Popa et al. [20] 2008 1 F 7 Hematologic malignancy L-AmB Survived after neurosurgical debridement
of the left temporal abscess
Garner et al. [21]. 2008 2 M; M 5; 15 Hematologic malignancy L-AmB, POS Survived
Ganesh et al. [22] 2008 1 M 14 DM 1 L-AmB, itraconazole Survived
Tarani et al. [23]. 2009 1 F 12 DM 1 L-AmB, GM-CSF, HOT, surgery, POS Survived
Ibrahim et al. [24]. 2009 1 F 12 DM 1 L-AmB, POS Survived
Skiada et al. [3]. 2009 1 M 2 Hematologic malignancy L-Am B, POS Vegetative state
Safder et al. [25]. 2010 1 F 12 Autoimmune hepatitis Surgery, L-AmB Survived with right eye exenteration
Nirmala et al. [26]. 2011 1 M 12 DM 1 L-AmB Survived
Prasad et al. [27]. 2012 1 F 15 Hematologic malignancy Surgery and L-AmB Deceased
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tions such as eye exenteration, partial loss of vision, in-
vasive surgery and nerve palsies. The overall mortality
was 20% in cases with type 1 diabetes and 50% in cases
with other predisposing factors. The mortality rate was
significantly higher when the central nervous system was
involved compared to sinus or sino-orbital involvement
only.
Discussion
The Zigomycosis’ predisposing factors are uncontrolled
diabetes, lymphomas, leukemias, renal failure, organ trans-
plant, long-term corticosteroid and immunosuppressive
therapy [28]. Hyperglycemia, usually with an associated
metabolic acidosis, is responsible for impaired neutrophil
function, neuropathies and vascular insufficiency leading
to a diminished resistance to infections and altered tissue
response. In ketoacidosis, the acid environment due to the
increase in glucose levels and the increase in levels of free
iron ions favour fungal growth [2].
The clinical onset of the Rhinocerebral Zygomycosis
in our report and in most cases is characterized by cra-
nial nerve palsies, facial/eye swelling and blindness, less
frequently by decreasing consciousness.
Mucormycosis is known for having a very poor prog-
nosis: survival rates are currently thought to exceed 80%.
Even with successful treatment, Mucorales can reappear
during future courses of chemotherapy and neutropenia
[29]. There may be predictive factors on the evolution of
complications: patients who presented with “blindness”
seem to have a higher prevalence of survival (p ≤ 0.04)
while patients who presented with “decreased conscious-
ness” seem to have an higher prevalence of death (p ≤
0.04). With the advent of potent antifungal medications,
a combination of surgery, medication and correction of
the underlying conditions has provided better outcomes
[26]. Surgery needs to be radical with an aim to remove
all devitalized tissue, and has to be repeated based on
disease progression. The new triazole POS has a broad
antifungal spectrum against filamentous fungi. The use of
POS seems to be associated with a high prevalence of sur-
vival with or without outcome (p ≤ 0.04). This is important
as standard therapy with amphotericin B often fails [23].
Conclusion
The zygomycosis may present with specific clinical
symptoms in patients with predisposing conditions.
“Blindness” seems to be correlated with survival predict-
ive factors while “decreased consciousness” seems to be
associated with severe outcome.
Early diagnosis of zygomycosis and meticulous broad
spectrum antifungal therapy are necessary to avoid the fur-
ther spread of infection, which may lead to high morbidity
and mortality. The timely use of POS alone or incombination with other therapies seems to be associated
with a high prevalence of survival with or without outcome.
Larger studies and populations are needed to test if these
relationships are casual or real. It is important to under-
stand and implement the treatment options which can help
to manage these patients with peculiar onset before the col-
tures results. Knowledge of potentially devastating compli-
cations can help to prevent the unfortunate consequences.
Written informed consent was obtained from the pa-
tient’s parents for publication of this Case report and any
accompanying images. A copy of the written consent is
available for review by the Editor-in-Chief of this journal.
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